| IED ID | IndEnz0010001295 |
| Enzyme Type ID | esterase001295 |
| Protein Name |
Phosphatidylcholine-sterol acyltransferase EC 2.3.1.43 1-alkyl-2-acetylglycerophosphocholine esterase EC 3.1.1.47 Lecithin-cholesterol acyltransferase Phospholipid-cholesterol acyltransferase Platelet-activating factor acetylhydrolase PAF acetylhydrolase Fragments |
| Gene Name | LCAT |
| Organism | Sus scrofa (Pig) |
| Taxonomic Lineage | cellular organisms Eukaryota Opisthokonta Metazoa Eumetazoa Bilateria Deuterostomia Chordata Craniata Vertebrata Gnathostomata (jawed vertebrates) Teleostomi Euteleostomi Sarcopterygii Dipnotetrapodomorpha Tetrapoda Amniota Mammalia Theria Eutheria Boreoeutheria Laurasiatheria Artiodactyla Suina Suidae (pigs) Sus Sus scrofa (Pig) |
| Enzyme Sequence | FWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNPDVVNWMCYRFTIWLDLNMFLPLGVDVPGFGKTYSVEYLDNSKAAPYDWRLEPSQQEEYYLKISLGAPWGGSDLHFEEGWYDLLAGLPAPGVEVYCLYGVGLPTPRXYIFDXGFPYXDPVQQQPVHLLPLPGTQHLNMVFSXQTLEXINAILLG |
| Enzyme Length | 188 |
| Uniprot Accession Number | P30930 |
| Absorption | |
| Active Site | ACT_SITE 169; /note=Charge relay system; /evidence=ECO:0000250|UniProtKB:P04180 |
| Activity Regulation | |
| Binding Site | |
| Calcium Binding | |
| catalytic Activity | CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + a sterol = a 1-acyl-sn-glycero-3-phosphocholine + a sterol ester; Xref=Rhea:RHEA:21204, ChEBI:CHEBI:15889, ChEBI:CHEBI:35915, ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=2.3.1.43; Evidence={ECO:0000255|PROSITE-ProRule:PRU10037, ECO:0000269|PubMed:8820107}; CATALYTIC ACTIVITY: Reaction=a 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-O-alkyl-sn-glycero-3-phosphocholine + acetate + H(+); Xref=Rhea:RHEA:17777, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30089, ChEBI:CHEBI:30909, ChEBI:CHEBI:36707; EC=3.1.1.47; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17778; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=(24S)-hydroxycholesterol + 1-hexadecanoyl-2-acyl-sn-glycero-3-phosphocholine = (24S)-24-hydroxycholesterol ester + 1-hexadecanoyl-sn-glycero-3-phosphocholine; Xref=Rhea:RHEA:43216, ChEBI:CHEBI:34310, ChEBI:CHEBI:72998, ChEBI:CHEBI:77369, ChEBI:CHEBI:82869; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43217; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=(24S)-hydroxycholesterol + 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine = (24S)-hydroxycholesterol 3-linoleoate + 1-hexadecanoyl-sn-glycero-3-phosphocholine; Xref=Rhea:RHEA:43224, ChEBI:CHEBI:34310, ChEBI:CHEBI:72998, ChEBI:CHEBI:73002, ChEBI:CHEBI:82875; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43225; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine + cholesterol = 1-hexadecanoyl-sn-glycero-3-phosphocholine + cholesteryl (5Z,8Z,11Z,14Z)-eicosatetraenoate; Xref=Rhea:RHEA:53448, ChEBI:CHEBI:16113, ChEBI:CHEBI:72998, ChEBI:CHEBI:73003, ChEBI:CHEBI:82751; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53449; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + cholesterol = 1-hexadecanoyl-sn-glycero-3-phosphocholine + cholesteryl (9Z-octadecenoate); Xref=Rhea:RHEA:53456, ChEBI:CHEBI:16113, ChEBI:CHEBI:46898, ChEBI:CHEBI:72998, ChEBI:CHEBI:73001; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53457; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine + cholesterol = 1-hexadecanoyl-sn-glycero-3-phosphocholine + cholesteryl (8Z,11Z,14Z)-eicosatrienoate; Xref=Rhea:RHEA:53464, ChEBI:CHEBI:16113, ChEBI:CHEBI:72998, ChEBI:CHEBI:84346, ChEBI:CHEBI:86121; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53465; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z-eicosatrienoyl)-sn-glycero-3-phosphocholine + cholesterol = 1-hexadecanoyl-sn-glycero-3-phosphocholine + cholesteryl (5Z,8Z,11Z)-eicosatrienoate; Xref=Rhea:RHEA:53460, ChEBI:CHEBI:16113, ChEBI:CHEBI:72998, ChEBI:CHEBI:86119, ChEBI:CHEBI:88752; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53461; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phosphocholine + cholesterol = (5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-cholesterol + 1-hexadecanoyl-sn-glycero-3-phosphocholine; Xref=Rhea:RHEA:53468, ChEBI:CHEBI:16113, ChEBI:CHEBI:72998, ChEBI:CHEBI:84969, ChEBI:CHEBI:86137; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53469; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine + cholesterol = 1-hexadecanoyl-sn-glycero-3-phosphocholine + cholesteryl (9Z,12Z)-octadecadienoate; Xref=Rhea:RHEA:53472, ChEBI:CHEBI:16113, ChEBI:CHEBI:41509, ChEBI:CHEBI:72998, ChEBI:CHEBI:73002; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53473; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(6Z,9Z,12Z-octadecatrienoyl)-sn-glycero-3-phosphocholine + cholesterol = (6Z,9Z,12Z-octadecatrienoyl)-cholesterol + 1-hexadecanoyl-sn-glycero-3-phosphocholine; Xref=Rhea:RHEA:53476, ChEBI:CHEBI:16113, ChEBI:CHEBI:72998, ChEBI:CHEBI:84786, ChEBI:CHEBI:88756; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53477; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(11Z,14Z,17Z-eicosatrienoyl)-sn-glycero-3-phosphocholine + cholesterol = (11Z,14Z,17Z-eicosatrienoyl)-cholesterol + 1-hexadecanoyl-sn-glycero-3-phosphocholine; Xref=Rhea:RHEA:53516, ChEBI:CHEBI:16113, ChEBI:CHEBI:72998, ChEBI:CHEBI:137411, ChEBI:CHEBI:137412; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53517; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphocholine + cholesterol = (9Z,12Z,15Z-octadecatrienoyl)-cholesterol + 1-hexadecanoyl-sn-glycero-3-phosphocholine; Xref=Rhea:RHEA:53520, ChEBI:CHEBI:16113, ChEBI:CHEBI:72998, ChEBI:CHEBI:84341, ChEBI:CHEBI:84789; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53521; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine + H2O = (9Z,12Z)-octadecadienoate + 1-hexadecanoyl-sn-glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:40811, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30245, ChEBI:CHEBI:72998, ChEBI:CHEBI:73002; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40812; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-hexadecanoyl-sn-glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:40427, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32395, ChEBI:CHEBI:72998, ChEBI:CHEBI:73003; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40428; Evidence={ECO:0000250|UniProtKB:P04180}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + a 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine = 1-hexadecanoyl-2-acetyl-sn-glycero-3-phosphocholine + 1-O-alkyl-sn-glycero-3-phosphocholine; Xref=Rhea:RHEA:53636, ChEBI:CHEBI:30909, ChEBI:CHEBI:36707, ChEBI:CHEBI:72998, ChEBI:CHEBI:75219; Evidence={ECO:0000250|UniProtKB:P04180};PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53637; Evidence={ECO:0000250|UniProtKB:P04180}; |
| DNA Binding | |
| EC Number | 2.3.1.43; 3.1.1.47 |
| Enzyme Function | FUNCTION: Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs). The cholesterol ester is then transported back to the liver. Also produced in the brain by primary astrocytes, and esterifies free cholesterol on nascent APOE-containing lipoproteins secreted from glia and influences cerebral spinal fluid (CSF) APOE- and APOA1 levels. Together with APOE and the cholesterol transporter ABCA1, plays a key role in the maturation of glial-derived, nascent lipoproteins. Required for remodeling high-density lipoprotein particles into their spherical forms (By similarity). Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines (PubMed:8820107). Catalyzes the hydrolysis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor or PAF) to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) (By similarity). Also catalyzes the transfer of the acetate group from PAF to 1-hexadecanoyl-sn-glycero-3-phosphocholine forming lyso-PAF (By similarity). Catalyzes the esterification of (24S)-hydroxycholesterol (24(S)OH-C), also known as cerebrosterol to produce 24(S)OH-C monoesters (By similarity). {ECO:0000250|UniProtKB:P04180, ECO:0000269|PubMed:8820107}. |
| Temperature Dependency | |
| PH Dependency | |
| Pathway | |
| nucleotide Binding | |
| Features | Active site (1); Chain (1); Glycosylation (1); Non-adjacent residues (10); Non-terminal residue (1) |
| Keywords | Acyltransferase;Cholesterol metabolism;Direct protein sequencing;Glycoprotein;Hydrolase;Lipid metabolism;Reference proteome;Secreted;Steroid metabolism;Sterol metabolism;Transferase |
| Interact With | |
| Induction | |
| Subcellular Location | SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:8820107}. Note=Secreted into blood plasma (PubMed:8820107). Produced in astrocytes and secreted into cerebral spinal fluid (CSF) (By similarity). {ECO:0000250|UniProtKB:P04180, ECO:0000269|PubMed:8820107}. |
| Modified Residue | |
| Post Translational Modification | |
| Signal Peptide | |
| Structure 3D | |
| Cross Reference PDB | - |
| Mapped Pubmed ID | - |
| Motif | |
| Gene Encoded By | |
| Mass | 21,238 |
| Kinetics | |
| Metal Binding | |
| Rhea ID | RHEA:21204; RHEA:17777; RHEA:17778; RHEA:43216; RHEA:43217; RHEA:43224; RHEA:43225; RHEA:53448; RHEA:53449; RHEA:53456; RHEA:53457; RHEA:53464; RHEA:53465; RHEA:53460; RHEA:53461; RHEA:53468; RHEA:53469; RHEA:53472; RHEA:53473; RHEA:53476; RHEA:53477; RHEA:53516; RHEA:53517; RHEA:53520; RHEA:53521; RHEA:40811; RHEA:40812; RHEA:40427; RHEA:40428; RHEA:53636; RHEA:53637 |
| Cross Reference Brenda |